Pharmacovigilance for ACTs in Africa
NCT01232530 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3176
Last updated 2015-07-31
Summary
This is a phase IV open label study assessing the safety and effectiveness of artemisinin derivatives-based combination therapy (ACT) when used on a large scale and under "real life" conditions.
Conditions
Sponsors & Collaborators
- collaborator OTHER
-
Centre Muraz
lead OTHER
Principal Investigators
-
Halidou Tinto, PharmD, PhD · Centre Muraz
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2012-12-31
- Completion
- 2013-12-31
Countries
- Burkina Faso
Study Locations
More Related Trials
-
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
NCT04695197 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Antimalarials in Uncomplicated Malaria
NCT00203801 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial on Effectiveness of ACTs in Ghana
NCT00374205 ·Status: TERMINATED ·Phase: PHASE4
-
Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso
NCT01697787 ·Status: COMPLETED ·Phase: PHASE4
-
Chemoprevention Efficacy Study in Burkina Faso
NCT05478954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection
NCT04264130 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger
NCT01755559 ·Status: COMPLETED ·Phase: PHASE4
-
ACT MALI: Treatment of Malaria Based on Combination Therapies
NCT00452907 ·Status: COMPLETED ·Phase: PHASE4
-
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
NCT01228344 ·Status: COMPLETED
-
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
NCT04618523 ·Status: COMPLETED ·Phase: PHASE4
-
Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania
NCT02199951 ·Status: UNKNOWN
-
Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission
NCT01603251 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
NCT00203736 ·Status: COMPLETED ·Phase: NA
-
In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso
NCT00808951 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
NCT00510159 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Methylene Blue Against Falciparum Malaria in Burkina Faso
NCT02851108 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Practices for Treating Severe Malaria Caused by P. Falciparum
NCT07027722 ·Status: COMPLETED
-
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana
NCT01459146 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies
NCT04265573 ·Status: COMPLETED
-
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
NCT06347471 ·Status: RECRUITING ·Phase: PHASE4
-
Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon
NCT01845701 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study
NCT00354380 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children
NCT01958905 ·Status: COMPLETED ·Phase: NA
-
ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan
NCT00158548 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance
NCT00440752 ·Status: COMPLETED